Marriott CFO Leeny Oberg to retire in 2026
Oberg has served as Marriott CFO since 2016 and as EVP of development since 2023, charged in the latter position with growing Marriott's global portfolio. She joined Marriott in 1999, serving in investor relations and financial management positions being named as CFO of Marriott's Ritz Carlton brand in 2013.
"Leeny's focus on value creation is evident in everything she does," Marriott CEO Anthony Capuano said in a statement. "Whether it was navigating the pandemic successfully, enhancing the company's cost competitiveness or having a disciplined and strategic approach to investing in growth, her impact on Marriott is long-lasting."
Upon Oberg's departure, she will be replaced as EVP and CFO by Mason, who has worked with Marriott since 1992. Her decades of experience in financial positions with the hotel company include a stint as CFO of Marriott's U.S. and Canada operations.
On Jan. 1, 2026, Hill will become Marriott's EVP and chief development officer and report to Oberg until she departs, then to Capuano, according to the company. Hill joined the company in 1997 and was a financial executive before joining the company's Asia-Pacific development team in 2005.
Mason and Hill "will bring an incredible depth of experience and demonstrated leadership to their roles, making them well positioned to drive Marriott's continued growth and success in the years to come," according to Capuano.
Source: Business Travel News
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Digital Trends
an hour ago
- Digital Trends
OpenAI lifts the lid on ChatGPT's daily prompt count — and it's big
Since its debut in November 2022, OpenAI's ChatGPT has rapidly become one of the fastest-growing consumer apps, and is up there with the likes of Instagram and Threads when it comes to records in user growth. The first public release of the company's AI-powered chatbot stirred global interest in generative AI, and since then the tool has only gained more momentum. OpenAI recently revealed to Axios that its AI chatbot now handles more than 2.5 billion user prompts per day worldwide, a remarkable leap from just 1 billion daily queries in December 2024. And of that figure, around 330 million prompts come from U.S.-based users alone. Recommended Videos To put that in perspective, it means ChatGPT is processing more than 1.7 million prompts every minute, or 29,000 every second. While ChatGPT's 2.5 billion daily prompts are far fewer than the 14 billion or so queries that Google Search handles on a daily basis, the usage of ChatGPT is fundamentally different in that it doesn't just serve up web links, but actively helps users carry out tasks, automate workflows, conduct deep research, provide tutoring, and a whole lot more besides. This important difference means that ChatGPT acts not just as an information finder, but also as a collaborative productivity tool. The rapid adoption of ChatGPT highlights its growing presence in our digital lives, and it's clear that the technology is reshaping the way we interact with information online. In just a short time, ChatGPT has gone from a curious new tool to an integral part of the online experience, and is now a key example of how AI is transforming our digital lives. But of course, ChatGPT is not the only generative-AI tool out there, with OpenAI facing tough competition from a growing field of rivals, including tech giants like Google, Microsoft, and Meta, as well as a slew of startups, all of them investing huge sums of money in AI productivity tools in a bid to get ahead. Indeed, the eagerness to dominate the sector has prompted some pushback, with generative-AI firms known to train their AI models on the work of creatives without permission and payment, though recently some have begun inking licensing deals with publishers, artists, and rights holders in a bid to address copyright concerns.
Bloomberg
an hour ago
- Bloomberg
Sanofi to Buy Vicebio for Up to $1.6 Billion in Respiratory Push
Sanofi agreed to buy UK vaccine developer Vicebio Ltd. for as much as $1.6 billion, as it seeks to expand in respiratory treatments. The pharmaceutical firm will pay $1.15 billion upfront, with potential milestone payments of up to $450 million based on development and regulatory achievements, according to a statement Tuesday. Vicebio is developing an early-stage combination vaccine candidate for respiratory syncytial virus, or RSV, and human metapneumovirus (hMPV), the company said.
Bloomberg
an hour ago
- Bloomberg
Insight with Haslinda Amin 7/22/2025
Bloomberg Insight Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
